These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 7915094
1. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH, Lin SN. Anticancer Res; 1994; 14(3B):1317-24. PubMed ID: 7915094 [Abstract] [Full Text] [Related]
2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M. J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [Abstract] [Full Text] [Related]
4. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients. Gorgoulis VG, Barbatis C, Poulias I, Karameris AM. Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234 [Abstract] [Full Text] [Related]
7. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma. Su JS, Arima K, Hasegawa M, Franco OE, Yanagawa M, Sugimura Y, Kawamura J. Hinyokika Kiyo; 2003 Nov; 49(11):649-58. PubMed ID: 14719452 [Abstract] [Full Text] [Related]
8. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome. Krüger S, Weitsch G, Büttner H, Matthiensen A, Böhmer T, Marquardt T, Sayk F, Feller AC, Böhle A. Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744 [Abstract] [Full Text] [Related]
10. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K. Anticancer Res; 1993 Nov; 13(4):1147-52. PubMed ID: 8102517 [Abstract] [Full Text] [Related]
11. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer. Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK. Anticancer Res; 1997 Nov; 17(2B):1417-23. PubMed ID: 9137508 [Abstract] [Full Text] [Related]
17. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W. Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):309-17. PubMed ID: 15890569 [Abstract] [Full Text] [Related]
18. [The molecular biology of bladder carcinoma]. Moreno Sierra J, Maestro de las Casas ML, Chicharro Almarza J, Ortega Heredia MD, López García-Asenjo J, Merino Sánchez C, Blanco Jiménez E, Silmi Moyano A, Rsesel Estévez L. Arch Esp Urol; 1997 Oct 01; 50(8):855-66. PubMed ID: 9463283 [Abstract] [Full Text] [Related]